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Background:  Primary  malignant  ﬁbrous  histiocytoma  (MFH)  of  the  duodenum  is  rare  and  a distinct  clinical
entity.
Case  report:  A  55-year-old  man  presented  with  a history  of  upper  gastrointestinal  bleeding,  vomiting  and
decreased  body  weight  over  the  past  2  months.  Abdominal  exam  showed  an  epigastric  mass  of  10 cm.  An
upper  gastrointestinal  endoscopy  documented  a tumor  in  the third  part  of  duodenum.  The  histopatho-
logical  examination  of  biopsy  has  concluded  a MFH.  Abdominal  CT  revealed  a large  and  heterogeneous
mass  of  10  cm  in  the  third  part  of the  duodenum.  The  intervention  was  conducted  by  way  of a  bi-subcostal
laparotomy.  Exploration  of  the  tumor  revealed  involvement  of the  third  part  of duodenum.  This  lesionomputed tomography adhered  and  invaded  the  inferior  vena  cava.  A  palliative  procedure  using  a gastro-entero-anastomosis
was  carried  out with  uneventful  postoperative  course.  Neither  adjuvant  chemotherapy  nor  radiotherapy
were  conducted.  The  patient  died  four  months  following  his  operation.
Conclusion: The  biological  behavior  of  malignat  ﬁbrous  histiocytomas  is extremely  aggressive  and  mainly
conditioned  by  size  and  histological  grading.  The  treatment  of  choice,  whenever  possible,  is  based  on
early  and  complete  surgical  excision  of  the  tumor.
© 2. Introduction
Malignant ﬁbrous histiocytoma (MFH) represents the most
ommon soft tissue sarcoma among adults.1–3 Visceral locations
re uncommon and primary duodenal MFH  is exceedingly rare.
.  Observation
We  present a case of a 63-year-old-man who was  admitted
o our hospital because of upper and highly abundant gastroin-
estinal bleeding (Hg = 4 g/dl), epigastric mass of 10 cm,  vomiting,
ower extremities edema and weight loss. After resuscitation and
tabilization of the patient (Hg = 11 g/dl), an upper gastrointestinal
ndoscopy was performed that showed a large tumor of the third
art of the duodenum, which was completely stenosed. Histologic
xamination of endoscopic biopsies of the tumor showed prolifer-
tion of both spindle (ﬁbroblast-like) and round (histiocyte-like)
ells, arranged in a cartwheel-like (storiform) and accompanied
y pleomorphic giant cells and inﬂammatory cells. The tumor was
hen classiﬁed as a storiform–pleomorphic type malignant ﬁbrous
istiocytoma (Fig. 1) according to the classiﬁcation suggested by
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Weiss and Enzinger.1 Abdominal CT scan (Fig. 2) indicated a large
and heterogeneous mass of 15 cm in the third part of the duode-
num. Neither locoregional nor distant metastatic invasions were
detected.
The intervention was  conducted by way  of a bi-subcostal laparo-
tomy. Exploration of the tumor revealed involvement of the third
part of the duodenum (Fig. 3). Moreover, solid and cystic lesions
were observed with the help of an intraoperative ultrasound exam-
ination. These lesions adhered and invaded the inferior vena cava.
A palliative procedure using a gastro-entero-anastomosis was  car-
ried out with uneventful postoperative course. Neither adjuvant
chemotherapy nor radiotherapy were conducted. The patient died
four months following his operation.
3. Discussion
Since the ﬁrst report of MFH  in 1964 by O’Brien and Stout,
MFH has been well recognized as the most common malignant
soft tissue tumor. It usually occurs in the deep planes of proximal
extremities, in the retroperitoneum and in the trunk, yet, it can
occur almost anywhere because of its mesenchymal origin, includ-
ing bones.4 Rarely, this tumor is primarily encountered in organs
such as the brain,5 lung,6 heart,7 breast,8 pancreas,9 gallbladder,10
Open access under CC BY-NC-ND license.or the alimentary tract.11 To date, and to the best of our knowledge,
only 6 cases of malignant ﬁbrous histiocytoma of the duodenum
have been reported. Five of them were primary MHF  including this
present case.12–15 Only one case of metastatic MFH  to the duode-
nse.
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Table 1
Up-to-date review of cases of primary malignant ﬁbrous histiocytoma of the duodenum.
Case n Source Age (sex) Symptoms Size (mm)
(Invasion,
metastasis)
Therapy Histologic type Follow up
1 Gilman et al (12)
1986
29  (female) Peritonitis 70 (None) Pancreatoduodenectomy Storiform-pleomorphic Few days (died)
2  Asai et al (13) 1987 61 (male) Epigastralgia 70 (None) Resection Pleomorphic 21 months
(alive)
3  Farinon et al (14)
1999
61  (female) Gastrointestinal
bleeding
90 (None) Pancreatoduodenectomy Storiform-Pleomorphic 2 months
(died)
4 Wang  et al (15)
2005
61  (male) Gastrointestinal
bleeding, weight
loss
150 (None) Pancreatoduodenectomy Storiform 24 months
(alive)
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Early and complete surgical excision may  be the only form of
management, which may  provide the patient with good results.
Our patient received a palliative procedure because of a local5  Present case 63 (male) Gastrointestinal
bleeding, weight
loss,  vomiting
150 (Inferio
vena cava)
um was described by Yarze and D’Agostino, and that occurred two
ears after surgical excision of the right anterior deltoid MFH.16 We
eviewed and summarized the ﬁndings from reported cases of pri-
ary duodenal MFH  as indicated in the English literature, as well
s presenting the ﬁndings from our case (see Table 1).
The  mean age of the patients was 55 years, with a range of 29–63
ears. The ratio of men  to women was 1.5. Only one case (1/5, 20%)
ad local invasion (i.e. inferior vena cava) and none had a distance
etastasis.
The common clinical symptoms were by order of frequency:
astrointestinal bleeding (3/5), abdominal pain (2/5) and weight
oss (2/5). No speciﬁc complaints or ﬁndings at physical examina-
ion were known to distinguish primary MFH  from other malignant
umors in the gastrointestinal tract. Therefore, the ﬁnal diagnosis
as made only after pathological and immunopathological exam-
nation of the tumor.
The  tumor diameter ranged from 70 mm to 150 mm.  In our
atient, the mass measured 150 mm in size. He died after 4 months.
There are four main morphologic variants of MFH: storiform–
leomorphic, myxoid, inﬂammatory, and angiomatoid.17 The
toriform–pleomorphic pattern (5/5, 100%) of duodenal MFH  was
he only variant.
ig. 1. Histopathological examination. Above: proliferation of histiocyte-like
lements,  occasionally multinucleated with large nuclei and nucleoli, and ﬁbroblast-
ike spindle cells, focally arranged in a storiform pattern (HE, 40×). Below: selected
rea  from the foregoing picture displays high mitotic activity with numerous abnor-
al forms (HE, 200×).gastroenteroanastomosis Storiform-pleomorph 4 months
(died)
From reports found in the literature, there is still no consensus
on the value of adjuvant or neoadjuvant chemo or radiation ther-
apy in primary MFH  of the duodenum. Conventional chemotherapy
for MFH  of the extremities has been reported to have little effect in
prolonging the overall survival of MFH  cases with small bowel.18–20Fig. 2. Abdominal computed tomograph scan demonstrated a heterogeneous mass
in the third part of duodenum (arrow). This mass contained a central necrosis.
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Cig. 3. Operative photograph showing a large tumor developed within a third part
f duodenum.
nvasion. Concerning prognostic factors, the site of the tumor
epresents undoubtedly an important prognostic factor for MFH
ocated in the retroperitoneum or abdomen. Late detection of these
umors due to their location is responsible for a poorer progno-
is, as compared with that of soft tissue tumors of the extremities.
eiss and Enzinger1 found that larger and more deeply located
umors metastasized more frequently, but size was  not as reli-
ble as the depth of the tumor when correlated with metastatic
otential.
. Conclusion
In conclusion, while occurring rarely, MFH  should be consid-
red in the differential diagnosis of large duodenal lesions. Tumor
ize, tumor site, adjacent organ invasion or metastases at diagnosis
emain the most important prognostic factor. The ﬁnal diagno-
is is made only after pathological examination of the tumor.
toriform–pleomorphic pattern in histology is the most common
ariant. When it is possible, the management of primary MFH  of
he duodenum should be surgery.onﬂicts of interest statement
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